Product Name: 5'-Deoxy-5-fluoro-N-(pentyloxy)carbonyl]cytidine 2',3'-diacetate CAS NO:162204-20-8
Chemical & Physical Properties:
Appearance :white powder
5'-deoxy-5-fluoro-N-[(pentyloxy)carbonyl]cytidine 2',3'-diacetate is a key intermediate for the synthesis of capecitabine. Capecitabine, produced by Roche ) Was developed. In April 1998, it was approved to be marketed in the United States under the trade name Xeloda. In 2000, it was approved for import by SFDA. The marketed dosage form is tablets.
If you are interested in our products or have any questions, please feel free to contact us!
Products under patent are offered for R & D purpose only. However, the final responsibility lies exclusively with the buyer.